German health-care group Fresenius SE & Co. (FRE.XE) reported double-digit-percent gains in earnings and sales for the first quarter.
The company said Wednesday sound business development at its units allowed for higher full-year profit guidance when excluding recent acquisitions.
Continue Reading Below
Quarterly net profit rose 28% to 457 million euros ($499 million) from EUR358 million on sales of EUR8.36 billion, which were up 19%. Earnings before interest and taxes increased 27% to EUR1.22 billion.
Profit, sales and EBIT beat analyst forecasts in a FactSet survey.
Write to Ulrike Dauer at firstname.lastname@example.org
(END) Dow Jones Newswires
May 03, 2017 01:58 ET (05:58 GMT)